The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Gray Media (GTN) .Gray Media currently has an average brokerage r ...

Core Viewpoint - Johnson & Johnson is currently under observation due to its stock performance and potential future direction, particularly in relation to earnings estimates and revenue growth [1][2]. Earnings Estimate Revisions - For the current quarter, Johnson & Johnson is expected to report earnings of $2.64 per share, reflecting a decrease of -6.4% year-over-year, with a slight increase of +0.5% in the Zacks Consensus Estimate over the last 30 days [5]. - The consensus earnings estimate for the current fiscal year is $10.62, indicating a growth of +6.4% from the previous year, with a minor adjustment of +0.1% in the last month [5]. - For the next fiscal year, the earnings estimate stands at $11, suggesting a growth of +3.6% compared to the prior year, with a recent increase of +0.2% [6]. - Johnson & Johnson holds a Zacks Rank 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [7]. Revenue Growth Forecast - The consensus sales estimate for the current quarter is $22.77 billion, representing a year-over-year increase of +1.4% [11]. - For the current fiscal year, the revenue estimates are $91.19 billion and $94.24 billion, indicating growth rates of +2.7% and +3.4%, respectively [11]. Last Reported Results and Surprise History - In the last reported quarter, Johnson & Johnson achieved revenues of $21.89 billion, a year-over-year increase of +2.4%, and an EPS of $2.77, up from $2.71 a year ago [12]. - The company exceeded the Zacks Consensus Estimate for revenues by +1.26% and for EPS by +7.78% [12]. - Johnson & Johnson has consistently beaten consensus EPS and revenue estimates over the past four quarters [13]. Valuation - Johnson & Johnson is graded B in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [17].

Company Overview - Cipher Mining Inc. (CIFR) shares increased by 15.9% to close at $5.68, supported by high trading volume, and have gained 42.7% over the past four weeks [1] - The stock price surge is attributed to the recent increase in Bitcoin prices, the largest cryptocurrency [1] Financial Performance - Cipher Mining is expected to report a quarterly loss of $0.12 per share, reflecting a year-over-year decline of 140% [2] - Projected revenues for the upcoming quarter are $48.37 million, which is a 31.4% increase compared to the same quarter last year [2] Earnings Estimates - The consensus EPS estimate for Cipher Mining has been revised 17.4% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [3] - A strong correlation exists between earnings estimate revisions and near-term stock price movements, suggesting potential for further strength in CIFR [2][3] Industry Context - Cipher Mining is part of the Zacks Technology Services industry, which includes other companies like Crane NXT (CXT) [4] - Crane NXT's consensus EPS estimate remains unchanged at $0.96, representing a year-over-year decline of 9.4% [5] - Both Cipher Mining and Crane NXT currently hold a Zacks Rank of 3 (Hold) [4][5]

Perimeter Solutions, SA (PRM) shares soared 8.5% in the last trading session to close at $15.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 13.5% gain over the past four weeks.Perimeter Solutions has opened a new PHOS-CHEK facility at McClellan Park in Sacramento, CA, one of world’s most advanced fire-retardant production facilities. Spanning an area of 110,000-square site will serve as a major hub for production and distrib ...

Company Overview - Ecovyst (ECVT) shares increased by 9.2% to close at $8.3, supported by high trading volume compared to normal sessions [1] - The stock had previously shown no significant movement over the past four weeks [1] Analyst Insights - A Citi analyst raised Ecovyst's price target from $7.50 to $10.00 while maintaining a Buy rating [2] - The analyst also revised EBITDA estimates for the second quarter of 2025 and full-year 2025, increasing them by 2% and 1% respectively [2] - The positive outlook is attributed to improved refinery utilization, stabilizing industrial production, and reduced tariff concerns [2] Earnings Expectations - Ecovyst is projected to report quarterly earnings of $0.12 per share, unchanged from the same quarter last year [3] - Expected revenues are $204.83 million, reflecting a 12.1% increase year-over-year [3] - The consensus EPS estimate has remained stable over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [4] Industry Context - Ecovyst operates within the Zacks Chemical - Specialty industry, which includes other companies like Daqo New Energy (DQ) [4] - Daqo's stock rose by 15.8% to $17.71, with a 12.8% return over the past month [4] - Daqo's consensus EPS estimate for the upcoming report is -$1.16, representing a 35.9% change compared to the previous year [5]

Personalis (PSNL) shares ended the last trading session 14.2% higher at $7.51. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 34.6% gain over the past four weeks.The sudden uptrend in the stock price can be attributed to the positive investor mindset regarding the continued growth in revenues from the sale of Personalis’ pharma tests and services, signifying increasing adoption of its technology.This provider of c ...

Core Viewpoint - Axos Financial (AX) shares have experienced a significant rally, driven by positive market sentiment and company-specific developments, including a decrease in the effective tax rate and upward revisions in earnings estimates [1][2][3]. Company Developments - Axos Financial shares increased by 6.2% in the last trading session, closing at $83.18, with notable trading volume [1]. - The company anticipates a reduction in its effective tax rate by approximately 3% starting in fiscal 2026, leading to a one-time, non-cash impairment charge of nearly $4 million in Q4 of fiscal 2025 [2]. - DA Davidson raised its price target for Axos Financial from $92.50 to $96.00, maintaining a buy rating, reflecting the company's strong growth and profitability metrics [3]. Earnings Expectations - The upcoming quarterly earnings report for Axos Financial is expected to show earnings of $1.84 per share, representing a year-over-year increase of 0.6%, with revenues projected at $312.44 million, up 7.4% from the previous year [4]. - The consensus EPS estimate for the quarter has been revised slightly higher over the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [5]. Industry Context - Axos Financial operates within the Zacks Financial - Miscellaneous Services industry, which is currently experiencing broader market optimism, contributing to investor confidence in financial services stocks [3][5]. - Another company in the same industry, HA Sustainable Infrastructure Capital, has seen its consensus EPS estimate remain unchanged at $0.64, reflecting a year-over-year change of 1.6% [6].

Company Overview - AirSculpt Technologies, Inc. (AIRS) shares increased by 8.7% to $5.25 in the last trading session, supported by higher-than-average trading volume [1] - The stock has gained 8.3% over the past four weeks, driven by stronger profitability and early success from its go-to-market strategy [1] Earnings Expectations - The company is projected to report quarterly earnings of $0.02 per share, reflecting a year-over-year decline of 77.8% [2] - Expected revenues are $45.64 million, which is a decrease of 10.5% compared to the same quarter last year [2] Earnings Estimate Revisions - The consensus EPS estimate for AirSculpt Technologies has been revised 100% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [3] - A strong correlation exists between earnings estimate revisions and near-term stock price movements, suggesting potential for further strength in AIRS [3] Industry Comparison - AirSculpt Technologies is classified under the Zacks Technology Services industry, which includes other companies like Ibotta (IBTA) [4] - Ibotta's consensus EPS estimate has remained unchanged at $0.18, representing a year-over-year increase of 113.6% [5] - Ibotta has a Zacks Rank of 3 (Hold), while AirSculpt Technologies holds a Zacks Rank of 2 (Buy) [4][5]

Arhaus, Inc. (ARHS) shares soared 6.5% in the last trading session to close at $9.23. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1.5% gain over the past four weeks.The company is prioritizing disciplined execution, targeted investments, and showroom expansion to support long-term profitable growth. In 2025, it plans 12 to 15 Total Showroom Projects and aims to reduce China sourcing to about 1% of total receipts.This company ...

Company Overview - Boston Beer (SAM) shares increased by 4.6% to $199.64 in the last trading session, following a period of 13.6% loss over the past four weeks, indicating a significant recovery in stock performance [1] - The company is experiencing benefits from brand strength, effective price realization, and procurement savings, which are mitigating the effects of inflationary costs [2] Financial Performance - Boston Beer is projected to report quarterly earnings of $4.40 per share, reflecting a year-over-year increase of 0.2%, with expected revenues of $598.55 million, up 3.4% from the same quarter last year [3] - The consensus EPS estimate for Boston Beer has remained stable over the last 30 days, suggesting that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Boston Beer is part of the Zacks Beverages - Alcohol industry, where another company, Molson Coors Brewing (TAP), saw a 2% increase in its stock price to $49.07, but has returned -9% over the past month [5] - Molson Coors has a consensus EPS estimate of $1.89, which has decreased by 0.7% over the past month, indicating a decline of 1.6% compared to the previous year [6]